osimertinib
astrazeneca
['osimertinib']
 depends on your definition of real world. as i see it in most of the real world providing access to osimertinib for all patients is impossible due to cost, so these strategies make sense #globonc
Geriatric Oncologist @incmnszmx #gerionc, Global Oncology. @ASCO BOD 20-24, FASCO. PhD @UNAM_MX Opinions my own. ???? https://t.co/GruVowk5sg…